JP2023554500A5 - - Google Patents
Info
- Publication number
- JP2023554500A5 JP2023554500A5 JP2023537572A JP2023537572A JP2023554500A5 JP 2023554500 A5 JP2023554500 A5 JP 2023554500A5 JP 2023537572 A JP2023537572 A JP 2023537572A JP 2023537572 A JP2023537572 A JP 2023537572A JP 2023554500 A5 JP2023554500 A5 JP 2023554500A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- heavy chain
- chain monomer
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025197132A JP2026041774A (ja) | 2020-12-18 | 2025-11-18 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063127408P | 2020-12-18 | 2020-12-18 | |
| US63/127,408 | 2020-12-18 | ||
| PCT/IB2021/061972 WO2022130342A1 (en) | 2020-12-18 | 2021-12-17 | Tetravalent fzd and wnt co-receptor binding antibody molecules and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025197132A Division JP2026041774A (ja) | 2020-12-18 | 2025-11-18 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023554500A JP2023554500A (ja) | 2023-12-27 |
| JP2023554500A5 true JP2023554500A5 (enExample) | 2025-05-20 |
| JP7778148B2 JP7778148B2 (ja) | 2025-12-01 |
Family
ID=82058983
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537540A Pending JP2024500839A (ja) | 2020-12-18 | 2021-12-17 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
| JP2023537572A Active JP7778148B2 (ja) | 2020-12-18 | 2021-12-17 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
| JP2025197132A Pending JP2026041774A (ja) | 2020-12-18 | 2025-11-18 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537540A Pending JP2024500839A (ja) | 2020-12-18 | 2021-12-17 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025197132A Pending JP2026041774A (ja) | 2020-12-18 | 2025-11-18 | 四価ＦＺＤ及びＷＮＴコレセプター（ｃｏ－ｒｅｃｅｐｔｏｒ）結合抗体分子並びにその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20250270332A1 (enExample) |
| EP (3) | EP4263618A4 (enExample) |
| JP (3) | JP2024500839A (enExample) |
| KR (1) | KR20230122077A (enExample) |
| CN (2) | CN116917332A (enExample) |
| AU (2) | AU2021399278A1 (enExample) |
| CA (2) | CA3204321A1 (enExample) |
| CL (2) | CL2023001768A1 (enExample) |
| IL (2) | IL303344A (enExample) |
| MX (1) | MX2023007103A (enExample) |
| WO (2) | WO2022130342A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118271444A (zh) | 2017-12-19 | 2024-07-02 | 瑟罗泽恩奥普瑞汀公司 | Wnt替代分子和其用途 |
| KR20220024460A (ko) * | 2019-06-11 | 2022-03-03 | 안틀라 테라퓨틱스 아이엔씨. | 다가 fzd 및 wnt 결합 분자 및 이의 용도 |
| WO2023250402A2 (en) * | 2022-06-22 | 2023-12-28 | Antlera Therapeutics Inc. | Tetravalent fzd and wnt co-receptor binding antibody molecules and uses thereof |
| CR20240266A (es) * | 2021-12-31 | 2024-11-11 | Surrozen Operating Inc | Compuesto específico de receptor wnt y método relacionado con este |
| EP4547713A4 (en) * | 2022-06-30 | 2026-07-08 | Univ Chicago | CD73 Targeting Polypeptides (NT5E) |
| WO2024227103A1 (en) * | 2023-04-27 | 2024-10-31 | Surrozen Operating, Inc. | Molecules modulating wnt signaling pathways and uses thereof |
| WO2025019458A2 (en) * | 2023-07-14 | 2025-01-23 | The Trustees Of Columbia University In The City Of New York | Specific blood retinal barrier defect in glaucoma directs new treatments and clinical tests |
| WO2025168716A1 (en) | 2024-02-07 | 2025-08-14 | Eyebiotech Limited | Compositions, doses, and methods for treatment of ocular diseases |
| WO2025176843A1 (en) | 2024-02-21 | 2025-08-28 | Ags Therapeutics Sas | Microalgae extracellular vesicle based gene therapy vectors (mev-gtvs), their preparation, and uses thereof |
| US20260070966A1 (en) * | 2024-09-06 | 2026-03-12 | Eyebiotech Limited | Multivalent fzd4, wnt co-receptor, and vegf receptor molecules and uses thereof |
| US20260092125A1 (en) * | 2024-09-06 | 2026-04-02 | Eyebiotech Limited | Multivalent fzd4, wnt co-receptor, and vegf binding molecules and uses thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69129154T2 (de) | 1990-12-03 | 1998-08-20 | Genentech, Inc., South San Francisco, Calif. | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
| JP2003516755A (ja) | 1999-12-15 | 2003-05-20 | ジェネンテック・インコーポレーテッド | ショットガン走査、すなわち機能性タンパク質エピトープをマッピングするための組み合わせ方法 |
| EP1513879B1 (en) | 2002-06-03 | 2018-08-22 | Genentech, Inc. | Synthetic antibody phage libraries |
| AU2004205631A1 (en) | 2003-01-16 | 2004-08-05 | Genentech, Inc. | Synthetic antibody phage libraries |
| US7785903B2 (en) | 2004-04-09 | 2010-08-31 | Genentech, Inc. | Variable domain library and uses |
| EP1957531B1 (en) | 2005-11-07 | 2016-04-13 | Genentech, Inc. | Binding polypeptides with diversified and consensus vh/vl hypervariable sequences |
| WO2007064919A2 (en) | 2005-12-02 | 2007-06-07 | Genentech, Inc. | Binding polypeptides with restricted diversity sequences |
| EP2016101A2 (en) | 2006-05-09 | 2009-01-21 | Genentech, Inc. | Binding polypeptides with optimized scaffolds |
| CN100592373C (zh) | 2007-05-25 | 2010-02-24 | 群康科技(深圳)有限公司 | 液晶显示面板驱动装置及其驱动方法 |
| EP2331136B1 (en) | 2008-09-26 | 2018-01-10 | OncoMed Pharmaceuticals, Inc. | Frizzled-binding agents and uses thereof |
| SG10201601747XA (en) | 2012-01-18 | 2016-04-28 | Genentech Inc | Anti-LRP5 Antibodies And Methods Of Use |
| DE102012202081A1 (de) | 2012-02-13 | 2013-08-14 | Osram Gmbh | Glühfaden für elektrische lampen und elektrische lampe sowie herstellungsverfahren für einen glühfaden |
| WO2014161037A1 (en) | 2013-04-03 | 2014-10-09 | Peter Maccallum Cancer Institute | Antibodies against human ryk and uses therefor |
| US9237411B2 (en) | 2013-07-25 | 2016-01-12 | Elwha Llc | Systems and methods for providing one or more functionalities to a wearable computing device with directional antenna |
| AU2014306564B2 (en) | 2013-08-14 | 2019-10-17 | Antlera Therapeutics Inc. | Antibodies against frizzled proteins and methods of use thereof |
| US20160208018A1 (en) | 2015-01-16 | 2016-07-21 | Juno Therapeutics, Inc. | Antibodies and chimeric antigen receptors specific for ror1 |
| WO2017127933A1 (en) | 2016-01-29 | 2017-08-03 | The Governing Council Of The University Of Toronto | Frizzled protein-binding agents and methods of use thereof |
| WO2018026942A1 (en) | 2016-08-02 | 2018-02-08 | Merrimack Pharmaceuticals, Inc. | Heteromeric polypeptides |
| US11039659B2 (en) | 2017-09-07 | 2021-06-22 | Nike, Inc. | Sole structure for article of footwear |
| US20210032352A1 (en) | 2018-02-14 | 2021-02-04 | Antera Therapeutics Inc. | Multivalent Binding Molecules Activating WNT Signaling and Uses Thereof |
| AU2019297522B2 (en) * | 2018-07-05 | 2026-04-23 | Surrozen Operating, Inc. | Multi-specific Wnt surrogate molecules and uses thereof |
| US10671121B2 (en) | 2018-09-14 | 2020-06-02 | Apple Inc. | Magnetic layout in electronic devices and accessory devices for electronic devices |
| KR20220024460A (ko) * | 2019-06-11 | 2022-03-03 | 안틀라 테라퓨틱스 아이엔씨. | 다가 fzd 및 wnt 결합 분자 및 이의 용도 |
-
2021
- 2021-12-17 CA CA3204321A patent/CA3204321A1/en active Pending
- 2021-12-17 KR KR1020237023863A patent/KR20230122077A/ko active Pending
- 2021-12-17 EP EP21905973.0A patent/EP4263618A4/en active Pending
- 2021-12-17 IL IL303344A patent/IL303344A/en unknown
- 2021-12-17 EP EP21905972.2A patent/EP4263617A4/en active Pending
- 2021-12-17 MX MX2023007103A patent/MX2023007103A/es unknown
- 2021-12-17 JP JP2023537540A patent/JP2024500839A/ja active Pending
- 2021-12-17 AU AU2021399278A patent/AU2021399278A1/en active Pending
- 2021-12-17 WO PCT/IB2021/061972 patent/WO2022130342A1/en not_active Ceased
- 2021-12-17 CN CN202180093862.1A patent/CN116917332A/zh active Pending
- 2021-12-17 CN CN202180093864.0A patent/CN116964102A/zh active Pending
- 2021-12-17 WO PCT/IB2021/061971 patent/WO2022130341A1/en not_active Ceased
- 2021-12-17 IL IL303342A patent/IL303342A/en unknown
- 2021-12-17 JP JP2023537572A patent/JP7778148B2/ja active Active
- 2021-12-17 AU AU2021404080A patent/AU2021404080A1/en active Pending
- 2021-12-17 CA CA3204322A patent/CA3204322A1/en active Pending
- 2021-12-17 US US18/267,914 patent/US20250270332A1/en active Pending
-
2022
- 2022-06-22 US US17/846,846 patent/US20230118983A1/en active Pending
-
2023
- 2023-06-15 CL CL2023001768A patent/CL2023001768A1/es unknown
- 2023-06-22 EP EP23741240.8A patent/EP4543921A2/en active Pending
- 2023-11-03 US US18/501,589 patent/US20240228631A9/en not_active Abandoned
-
2025
- 2025-05-20 CL CL2025001491A patent/CL2025001491A1/es unknown
- 2025-11-18 JP JP2025197132A patent/JP2026041774A/ja active Pending